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Background: Hypertension is a dangerous condition that precedes many cardiovascular 
events including myocardial infarction, stroke, transient cerebral ischemic attack and 
symptomatic aortoiliac occlusive disease. While it is universally accepted that arteries 
stiffen with age, the physiological reason for this is debated. In a previous study, by Dr. 
Shana Roach Watson it was shown that collagen fibers re-orient themselves in a 
circumferential direction, resulting in increased arterial stiffness. The study hypothesized 
that this collagen remodeling could be a result of decreased nitric oxide production. 
Methods: This study measured nitric oxide in two different ways, indirectly via 
Immunoperoxidase staining for eNOS and directly via diaminofluorescein-2.  In the 
design there were two timepoints: 6 weeks and 6 months. Groups of mice (n=5) were 
placed on either a high fat Western diet or a chow diet for 6 months. Young mice at 6 
weeks of age on chow diet served as the baseline. For the immunoperoxidase staining 
procedure, 6 µm sections were stained via immunohistochemistry. For the 
diaminofluorescein-2 assay, the thoracic aorta (from the aortic arch to the diaphragm) 
was cut longitudinally and pinned en face onto culture dishes with a 3-millimeter-thick 
layer of black wax. They were stained with diaminofluorescein-2, and images were taken 
with the In Vivo Imaging System (IVIS).  
v 
Results: There was no significantt difference in endothelial Nitric Oxide Synthase 
(eNOS) expression between the groups for the immunoperoxidase staining. There was 
also no significant difference in Nitric Oxide release between the groups for the DAF-2 
staining. 
Conclusion: The lack of a significant decrease with age disproves our hypothesis that a 
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Arterial stiffness plays an important role in predicting major cardiovascular events 
including myocardial infarction, stroke, transient cerebral ischemic attack and 
symptomatic aortoiliac occlusive disease(Perticone et al., 2001a). According to the World 
Health Organization, 17.9 million people die each year from cardiovascular events such 
as these, an estimated 31% of all deaths worldwide. Arterial stiffness is defined as an 
“artery’s ability to resist distension when a force is applied to it” (Greenwald, 2007). 
While arterial stiffening occurs independently of atherosclerosis, it occurs in the same 
context as atherosclerosis and diabetes and is a precursor for hypertension. Hypertension 
can lead to heart failure due to the sustained increase in vascular load it imposes upon the 
heart(Kamberi, Gorani, Hoxha, & Zahiti, 2013).  
The amount of blood the heart can pump through the body is determined by the 
pressure or load in the systemic circulation, known as the afterload (Ooi, Chung, & Biolo, 
2008). Therefore, hypertension caused by arterial stiffness can severely impair cardiac 
output. Arterial stiffness causes the systolic blood pressure to increase leading to an 
upsurge in left ventricular workload and left ventricular hypertrophy (Agabiti-rosei & 
Rizzoni, 2009; Ooi et al., 2008; Watabe & Hashimoto, 2006). Pulse wave velocity 
(PWV) is a measure of arterial stiffness and a very good predictor of cardiovascular 




the arteries at a given velocity. There is a partial reflection of this forward wave that in 
normal arteries returns to the aorta and augments the diastolic pressure(Greenwald, 2007; 
Ooi et al., 2008). When arteries are stiff, the pulse wave is transmitted at a higher velocity 
and the reflected wave augments systolic pressure instead of diastolic pressure resulting 
in summation with the anterograde wave and increased peak pressure (see figure 1.1) 
(Greenwald, 2007; Ooi et al., 2008). This phenomenon magnifies peripheral systolic 
blood pressure and pulse pressure as well as worsening cardiac systolic performance and 
efficiency.   
It is universally accepted that arteries stiffen with age, but the physiological 
reason for this is debated (see figure 1.2). Past theories have implicated altered 
hemodynamics; however, the only known processes involved in arterial stiffening are 
elastic fiber degradation, fibrosis, and medial calcification(Greenwald, 2007; Harvey, 
Montezano, Lopes, Rios, & Touyz, 2016b, 2016a). Elastic fibers, one of the components 
of the lamellar unit in the medial layer of the arterial wall, give the arterial wall its 
elasticity. As aging occurs, elastic lamellae are broken down by proteolytic enzymes such 
as serine and cysteine proteases as well as matrix metalloproteases, and then the elastin is 
replaced with collagen which is 100-1000 times stiffer than elastin(Galis, 2002; 
Greenwald, 2007; Jacob, 2003). Along with protease activity, fatigue failure can also 
contribute to the fragmentation of elastin(Greenwald, 2007). The remaining elastin 
undergoes calcification, reducing the pliability of the remaining elastic 
lamellae(Greenwald, 2007). The reduced elastin content and the increased collagen 
deposition (fibrosis) lead to arterial stiffening (Greenwald, 2007; Harvey et al., 2016b; 




This study builds on a previous study by Shana Roach Watson on “Factors 
Influencing the Collagen Fiber Angle Distribution in the Mouse Aorta.” Dr. Watson 
hypothesized that changes in the active and passive forces in the arterial wall, related to 
hypertension and arterial dysfunction, cause collagen fibers to re-orient themselves in a 
circumferential direction, resulting in increased arterial stiffness (Watson, 2016). To test 
this hypothesis, the 3D collagen fiber angle distribution was obtained from mice of 
various genotypes (Apolipoprotein E (Apo E ) knockout (KO) vs. apoE MMP12 double 
knockout), diet (chow diet vs Western diet), and age (6 weeks vs 6 months). To examine 
the effects that hemodynamic forces have on vascular remodeling, the blood pressure and 
blood velocity were measured and compared, along with the extracellular matrix 
composition and the collagen fiber angle. It was also hypothesized that this type of 
collagen remodeling could be a result of decreased nitric oxide production. To investigate 
the role of nitric oxide production in collagen remodeling, endothelial nitric oxide 
synthase expression was quantified via immunohistochemistry and then compared with 
the previous results(Watson, 2016).  
Dr. Watson’s results for endothelial nitric oxide synthase expression were 
inconclusive, so we decided to repeat and expand upon the study by comparing two 
different approaches to measuring nitric oxide production: indirect and direct (Watson, 
2016). Measuring the nitric oxide levels in tissues is imperative for understanding its role 
in physiological and pathological processes; however, because of its short lifespan (less 
than 1 s), nitric oxide detection is difficult and complex (Blitterswijk et al., 1992). 
Therefore, an indirect approach that quantifies the amount of endothelial nitric oxide 




is often used to indicate potential for NO production. An alternative method is directly 
measuring nitric oxide using DAF-2.  
Specific Aim 1: To measure potential for nitric oxide production in the arterial 
wall of mice according to age (6 week vs. 6 month) and diet (Western vs. chow). To 
characterize the distribution of endothelial nitric oxide synthase expression as a marker of 
endothelial dysfunction and to relate nitric oxide production to existing data on collagen 
fiber angle.  
Specific Aim 2: To directly measure nitric oxide production in the arterial wall of 
mice according to age (6 week vs. 6 month) and diet (western vs. chow) using the DAF-2 
method. To characterize the distribution of nitric oxide production as a marker of 







Figure 1.1: Ageing of the Conduit Arteries: The thin grey line represents the 
forward-going pressure wave while the dashed line represents the reflected 
wave. The summation of these waves is represented by the thick black line. 
Young mice have more compliant arteries so the PWV is slower and augments 
diastolic pressure. Older mice have hypertensive arteries resulting in a fast 
PWV which augments systolic pressure. Adapted from ‘Ageing of the Conduit 
Arteries,’ by SE Greenwald, 2007, Journal of Pathology, 211, p. 157-172. 
Copyright 2007 by the Pathological Society of Great Britain and Ireland.   
 
Figure 1.2: Age and Pulse Pressure Amplification Pulse pressure waves in 
patients 24,54 and 68 years of age. Adapted from ‘Vascular Stiffening and 
Arterial Compliance’ by E. L. Schiffrin, 2004, American Journal of 
Hypertension. p39-48. Copyright 2004 by the Canadian Institute of Health 





BACKGROUND AND REVIEW OF LITERATURE 
2.1 The Arterial Wall 
 To understand the process of vascular remodeling, it is first necessary to consider 
the normal structure of the arterial wall.  The vascular wall is composed of three layers; 
the intima, the media and the adventitia (Gao, 2017; Jacob, 2003).  The extracellular 
matrix provides a structural framework for the cells of these three layers (see figure 2.1) 
(Gao, 2017).  
The tunica intima is the innermost layer of the blood vessel wall (Pugsley & 
Tabrizchi, 2001). Endothelial cells, which play an important role in recruiting smooth 
muscle cells to the vascular wall, sit on the basement membrane of the tunica intima 
(Wagenseil, 2010). The basement membrane, or basal lamina, contains type IV collagen 
and binds the endothelium to connective tissue (Jacob, 2003). The tunica intima plays a 
crucial role in altering blood flow by releasing local chemicals called vasodilators which 
can relax smooth muscle cells.  The intima is separated from the media by a dense elastic 
membrane called the internal elastic lamina (IEL) (Gao,  2017; Wagenseil, 2010). This 
membrane is penetrated by pores where exchange of materials occurs between the 
various layers. The fact that endothelial cells can also produce elastin suggests that they 




(Wagenseil., 2010). Vascular aging results in the migration of medial vascular smooth 
muscle cells (VSMCs) across the IEL, causing the intima to thicken (Greenwald, 2007).  
  The media is the thickest layer of the vessel wall and is comprised of smooth 
muscle cells, elastic fibers, collagen and ground substance in the form of a 
mucopolysaccharide gel (Lesauskaite et al., 2001; Mark, 1981; Robert & Birembaut, 
1989; Shadwick, 1999).  Thick elastin bands form concentric elastic lamellae between the 
smooth muscle cell layers, while finer elastin fibers form networks between these 
lamellae (Gao, 2017). The elastin functions as an elastic reservoir that distributes stress 
evenly onto the collagen fibers in the interstices which bind the tunica media to the inner 
and outer tunics (Wagenseil, 2010). An elastic lamella and the smooth muscle cells 
surrounding it is called a lamellar unit (Shadwick, 1999). In stress-free conditions the 
collagen of the media displays a wavy pattern of fibers, while in a high stress state the 
collagen fibers, elastic laminae and smooth muscle cells straighten to display a 
circumferentially aligned pattern (Wagenseil, 2010). There is another dense elastic 
membrane called the external elastic lamina that separates the media and the adventitia 
which is made up of collagen fibers and fibroblasts (Gao, 2017).  
The tunica externa or the adventitia is the outermost layer of the arterial wall and is 
comprised primarily of fibro-elastic connective tissue (Pugsley & Tabrizchi, 2001). Vasa 
vasorum, lymphatic vessels, nerves, fibroblasts, histological ground matrix, immune cells 
and vascular progenitor cells are also found in the adventitia (Gao, 2017). The fibroblasts 
produce the extracellular matrix as well as the matrix metalloproteinases. When exposed 
to conditions that are less than ideal, these fibroblasts can release growth factors, 




(Gao, 2017). The collagen fibers that comprise the adventitia are mainly Type I and are 
arranged within the ground matrix so that they form a fibrous tissue (X. Liu, 1997). 
Collagen and elastin are the main extracellular matrix components of the arterial 
wall and the absolute and relative quantities of these proteins determine its biomechanical 
properties (Jacob, 2003; Robert & Birembaut, 1989; J. E. Wagenseil & Mecham, 2013). 
Matrix metalloproteinases (MMPs), such as collagenases and elastases, are capable of 
degrading elastin and collagen. Between the ages of 20 and 90 years old, the intima-
media thickness of the human carotid artery increases two to threefold (Jacob, 2003). 
Most of this increase in thickness is due to an increase in absolute collagen content. The 
absolute elastin content stays the same while the relative elastin content significantly 
decreases (Jacob, 2003). These changes result in the stiffening of the arteries. The arterial 
compliance is determined by the ratio of elastin and collagen (Jacob, 2003).  
 2.2 Collagen 
Collagen is the most abundant protein in mammals and is the main load carrying 
element in the arterial walls (Fratzl, 2008; Gelse, Po, & Aigner, 2003). Collagens are 
molecules found in the fibrillar and microfibrillar networks of the extracellular matrix 
that are essential for maintaining structural integrity as well as for tissue assembly or 
maintenance (Gelse et al., 2003). Collagen is a right-handed triple helix with a one 
residue stagger comprised of three parallel polypeptide strands (α chains) in a left-
handed, polyproline II-type helical conformation coil ( Gelse et al., 2003). The three 
chains are held together by inter-chain hydrogen bonds and electrostatic interactions. 




account for 20% of the total and every third residue is glycine, following a Gly-X-Y 
pattern (Gelse et al., 2003; Jacob, 2003; Robert & Birembaut, 1989). Contiguous to the 
triple helical domains are non-Gly-X-Y regions abbreviated as NC for non-collagenous 
(Gordon & Hahn, 2010). Since many different molecules contain Gly-X-Y triple helix 
repetitions, the defining feature that makes a molecule collagen is somewhat subjective 
(Gelse et al., 2003; Kadler, Baldock, Bella, & Raymond, 2007).  Collagen can be a 
heterotrimer or a homotrimer. A homotrimer has three identical alpha chains (collagens 
II, III, VII, VIII, X) while a heterotrimer has at least one distinct alpha chain (collagens I, 
IV, V, VI, IX, XI) (Gelse et al., 2003). To date, more than 20 types of collagen have been 
discovered; however, the most common type of collagen is Type I (Fratzl, 2008; Gordon 
& Hahn, 2010). Type I collagen is considered the exemplary collagen (Kadler et al., 
2007). It is heterotrimeric, triple helical, and has no imperfections or interruptions in the 
triple helix, where imperfections are defined as one to three atypical residues in the triple 
helix (Kadler et al., 2007).  
 The structure and function of collagens are very diverse. This diversity is a direct 
result of having multiple α chains that can differ from one another, several molecular 
isoforms, supramolecular structure and the use of alternative promoters and alternative 
splicing (Ricard-blum, 2011). Because of this, collagens are divided into subfamilies 
based on their supramolecular structure: fibril forming collagens, fibril-associated 
collagen, network forming collagens, anchoring fibrils, transmembrane collagens and 
basement membrane collagens (Gordon & Hahn, 2010). 
 Fibrillar collagens, the most abundant, are characterized by their torsional 




2011). Because of the regular staggering of triple helical molecules, the fibril forming 
collagens have a periodic structure. Fibrillar collagens are also the only collagens to have 
a perfect Gly-X-Y triplet structure. All other collagens or non-fibrillar collagens have at 
least one imperfection (Gordon & Hahn, 2010). Fibril forming collagens are synthesized 
as procollagen, containing N and C propeptides at each end of the triple helical domain 
until they are cleaved by proteinases in a process called fibrillogenesis. Type I collagen is 
the most abundant fibril-forming collagen. It is also a heterotrimer which is unusual 
because most collagens are homotrimers. Other fibril forming collagens include types II, 
III, V, and XI (Gelse et al., 2003).   
 The best example of a microfibrillar collagen is Type VI collagen (Gelse et al., 
2003). This collagen is unusual because it has three distinct α chains (α1, α2, α3) which 
have short triple helical regions and extended globular termini. Before being utilized in 
the body, collagen VI undergoes extensive modification until it resembles tetramers 
which are secreted into the extracellular matrix and form a vast microfibrillar network 
that can be found in any connective tissue. 
 Type IV collagen is the prototypical network forming collagen and the most 
important structural component of basement membranes (Mark, 1981; Robert & 
Birembaut, 1989). Head to head interactions of two trimeric NC1 domains form 
hexamers which make up a supramolecular network that incorporates laminins, nidogens 
and other components (Gelse et al., 2003). This collagen forms chicken wire-like two-





 Several types of collagen have been isolated in arteries including types I, III, IV, 
V, and VI (Jacob, 2003; Robert & Birembaut, 1989; J. Wagenseil & Mecham, 2010). The 
adventitia and media of the arterial wall are rich in interstitial collagens type I and III 
(Robert & Birembaut, 1989). Type I tends to be near the surface of the smooth muscle 
cells while type III tends to be closer to the elastic lamellae. These two types of collagen 
are largely responsible for the tensile strength of vascular walls (Maurel et al., 1987). 
Furthermore, age-related vascular dysfunction is characterized by abundant type I 
collagen, produced by smooth muscle cells, migrating into the intima (Kohn, Lampi, & 
Reinhart-King, 2015).  
2.3 Atherosclerosis 
Atherosclerosis is defined by marked narrowing of large elastic arteries due to the 
buildup of plaque. Atherosclerosis can be divided into three stages: fatty streak, fibrous 
plaque and complicated lesion. A fatty streak is an early lesion comprised of 
subendothelial aggregations of cholesterol-laden macrophages also known as foam cells 
(Insull, 2009). These early lesions are the body’s immune response to excess cholesterol 
in the vessel wall. As low-density lipoprotein (“bad cholesterol”) accumulates in the 
vessel wall, the body’s immune system sends macrophages to remove it; however, these 
macrophages fail to remove the fatty deposits and instead become part of the plaque 
(Insull, 2009; Jara, Medina, Vera-Lastra, & Amigo, 2006). Eventually, these fatty streaks 
turn into fibrous plaques. Smooth muscle cells, macrophages, and lymphocytes form 
plaques in the tunica intima of the blood vessel. The smooth muscle cells secrete 
proteoglycans which bind lipids (Greaves & Gordon, 2001; Insull, 2009). These lipids 




forms a lipid-rich ‘necrotic core’ surrounded by a fibrous cap consisting of SMCs and a 
proteoglycan-collagen matrix (Boon, Greenberg, Kitslaar, Tordoir, & Daemen, 2016; 
Insull, 2009).  With time, the fibrous cap can weaken and become susceptible to rupture. 
When rupture does occur, it exposes the necrotic core to the bloodstream (Insull, 2009). 
The body treats this as an injury and a blood clot forms, resulting in a complicated lesion. 
If the blood clot grows sufficiently large or breaks off, it can occlude the artery, which 
can cause a stroke or myocardial infarction.   
Because wild type mice do not develop spontaneous atherosclerosis, we use 
apolipoprotein E knockout mice(Tian, Li, Liu, Tong, & Zhang, 2016). Lipoproteins are 
responsible for carrying cholesterol through the blood stream and are essential for 
cholesterol clearance from the circulation (Arnold von Eckardstein, Jerzy-Roch Nofer, 
2001). Apolipoprotein E is a major component of specific lipoproteins called very low-
density lipoproteins (Arnold von Eckardstein, Jerzy-Roch Nofer, 2001; Tian et al., 2016). 
A major function of VLDLs is to remove excess cholesterol from the blood and carry it to 
the liver for processing (Arnold von Eckardstein, Jerzy-Roch Nofer, 2001). Without the 
gene that codes for apolipoprotein E, mice will become susceptible to developing 
spontaneous atherosclerosis (Tian et al., 2016). 
2.4 Vascular Remodeling    
The arterial wall is a dynamic structure that adapts to various stimuli by 
rearranging its cellular and extracellular components, often to maintain adequate blood 
flow and to regulate arterial wall stress (Rudic, 1998). This remodeling of the vessel wall 




pressure and blood flow (Renna, Heras, & Miatello, 2013). Several types of structural 
adaptations seen in vascular remodeling are shown schematically in figure 2.2. When 
structural adaptations are based on changes in blood pressure, the diameter of the lumen 
remains constant while the media to lumen ratio changes as shown in A and B in figure 
2.2. When vascular remodeling structural adaptations are based on changes in blood flow, 
the diameter of the lumen changes as seen in C and D in figure 2.2. E and F represent a 
response to injury such as atherosclerotic lesion growth (Renna et al., 2013).  
 As stated above, one effect of vascular remodeling is to regulate arterial wall 
stress. It has been theorized that when large arteries are in an exclusively hypertensive 
state (have a high P), they undergo inward hypertrophic remodeling, thereby decreasing 
the r/h ratio and maintaining the same arterial wall stress (see equation 1). This can be 
seen in figure 2.2.    
 Vascular remodeling involves changes in at least four cellular processes: cell 
growth, cell death, cell migration, and synthesis/degradation of the ECM. These 
processes are influenced by local growth factors, vasoactive substances and 
hemodynamic stimuli. During remodeling, smooth muscle cells proliferate and migrate 
while synthesizing major components of the extracellular matrix such as proteoglycans 
and collagen types I, III, IV and V, as well as MMPs and TIMPs (Ishikawa et al., 2000). 
Matrix metalloproteinases degrade collagen types I, II, III, and IV and other extracellular 






2.5 Mathematical Models of Vascular Growth and Remodeling 
 Vascular deformation can occur as a response to the active and passive forces 
acting on the vessel wall. Noncontracting muscle and ECM deform passively in response 
to hemodynamic forces, produce passive forces while vascular smooth muscle cells 
produce active forces. These forces and the deformation that they cause can be 
represented mathematically in various ways. One of these models is called a Mixture 
Model, meaning that each load-bearing component of the arterial wall deforms in unity 
with the rest of the wall but can occupy different states (stressed state vs. stress-free state) 
(Gleason & Humphrey, 20004). This model is unlike its predecessor, the ‘kinematic 
growth’ model put forward by Skalak, because it focuses on how remodeling occurs 
rather than simply its consequences. The mixture model is an extension of a 2D model 
that predicts arterial wall mechanics using the following equilibrium relations:  
   
   
   
   
 










 Various studies suggest that a malfunction in vascular remodeling contributes to 
hypertension as well as atherosclerosis (Sonoyama, Greenstein, Price, Khavandi, & 
Heagerty, 2007). Human and animal subjects with hypertension experience heightened 
peripheral vascular resistance due to impaired structural adaptation to high blood pressure 




a lack of endothelium dependent relaxation of the blood vessels. The corresponding 
structural change is described as an increase in the cross-sectional area of the media 
relative to the area of the lumen; this change can result from abnormal luminal 
remodeling resulting in a narrower lumen, from an increase in wall thickness, or from a 
decrease in external diameter of the vessel which is accompanied by a decrease in the 
diameter of the lumen (Sonoyama et al., 2007). Nitric oxide, a vasodilator, has been 
implicated by long term pharmacological studies as an important mediator which can 
regulate wall to lumen ratios. These long-term pharmacological studies used inhibitors of 
nitric oxide such as nitro-l-arginine methyl ester (L-NAME) to cause endothelial 
dysfunction (defined as a lack of nitric oxide) and therefore increased hypertension 
(Jacob, 2003).   
 
2.6 Arterial stiffness and endothelial dysfunction as predictors of cardiovascular 
events 
In 2001, a study by Francesco Perticone and colleagues proved that forearm 
endothelial dysfunction in hypertensive patients predicts cardiovascular events 
demonstrating that research in endothelial dysfunction and hypertension has clinical 
value.  In this study, 225 patients with a history of hypertension were given 3 incremental 
doses of acetylcholine, with each injection followed by measurement of the patient’s 
forearm blood flow. The patients were observed over the course of their lives and 
cardiovascular events were recorded. The patients that had the lowest percent increase in 
forearm blood flow had the highest rate of cardiovascular events (Perticone et al., 2001b). 
Perticone’s study was similar to Al Suwaidi’s 2000 study, except instead of 




related endothelial dysfunction in general to cardiovascular events. 168 patients showing 
symptoms of coronary atherosclerosis were selected. Coronary blood flow was calculated 
after multiple infusions of acetylcholine. The participants were separated into 3 different 
groups based upon their response to the acetylcholine. Results showed that the group that 
had the lowest response to acetylcholine, had the highest rate of cardiovascular events 
(Suwaidi et al., 2000).  
In 2002, Blacher used pulse wave velocity (PWV), a linearized measure of arterial 
stiffness, to predict mortality in end stage renal disease (ESRD) in a population of 241 
patients undergoing hemodialysis.  Patients had no history of cardiovascular disease and 
had been on hemodialysis for at least 3 months. Transcutaneous Doppler flow recordings 
were used to quantify aortic PWV. 469 subjects without ESRD were used to determine 
multi-adjusted PWV cut-off values by constructing a nomogram.     Ninety-one deaths 
were recorded, with 58 of those being cardiovascular-related. The patients with a positive 
PW./V index had a two-fold increased risk of overall mortality (Blacher, Safar, Pannier, 
Guerin, & Marchais, 2002). During this time, using increased wave reflection as an 
indicator of vascular aging was not well-established. Wave reflection intensity was only 
found to be an independent predictor of cardiovascular events in elderly patients with end 
stage renal disease and following percutaneous coronary intervention. However, in March 
2010 Kang-Ling Wang hypothesized that the usefulness of wave reflection intensity in 
predicting cardiovascular events was underestimated since measures such as AI 
(augmentation index) and Pa (augmented pressure) are affected by the reflected wave 




Kang-Ling Wang measured the carotid-femoral PWV using sequential 
nondirectional Doppler flow velocity signals of 1272 normotensive and untreated 
hypertensive Taiwanese subjects. Individual signals were subject to batch analysis and 
five to ten waves were averaged to get a single wave. After a median of 15 years, 225 
deaths had occurred with 64 of those deaths being cardiovascular. After the population 
was stratified by age, PWV, Pa, and backward wave amplitudes (Pb) were predictive of 
cardiovascular mortality (Wang, 2010). 
2.7 Nitric Oxide and its Potential Role in Vascular Remodeling 
Nitric oxide is a gaseous, free radical that plays a key role in signaling pathways 
which modulate vascular tone, thrombogenicity and leukocyte-endothelium adhesion 
(Blitterswijk et al., 1992; Kojima et al., 1998). Nitric oxide is referred to as an 
endothelium-derived relaxing factor because it promotes smooth muscle relaxation which 
dilates blood vessels (Massion, Feron, Dessy, & Balligand, 2003). Dilation (or 
vasorelaxation) in turn raises blood supply and lowers blood pressure. This is 
accomplished in a series of steps. First nitric oxide diffuses into the smooth muscle cells 
surrounding small blood vessels and binds to guanylate cyclase, activating it (Manning, 
2005). The activated guanylate cyclase then forms cyclic guanosine monophosphate (or 
cGMP) by cleaving two phosphate groups from guanosine triphosphate (Manning, 2005). 
cGMP phosphorylates proteins such as myosin, causing the cell to relax and the vessel to 
dilate. Nitric oxide prevents thrombosis by inhibiting platelet aggregation and adhesion to 
the vascular wall. It also decreases the expression of chemoattractant protein monocyte 
chemoattractant protein 1, thereby preventing leucocyte adhesion to and migration into 




NO protects against a later phase of atherogenesis by inhibiting the DNA synthesis, 
mitogenesis, and proliferation of smooth muscle cells (Förstermann & Sessa, 2012).  
NO is produced by three isoforms of nitric oxide synthase (NOS) found in various 
cell types of the vascular wall. (V. W. T. Liu & Huang, 2008). Neuronal NOS is 
expressed in endothelial and smooth muscle cells (Zhao et al., 2015). Inducible nitric 
oxide synthase is also found in smooth muscle cells but its expression is reduced by 
endothelial cells (Gonzalez-Fernandez et al., 1998). Endothelial nitric oxide synthase 
(eNOS, NOS3) is found in the endothelial cells of the arterial wall.  
 This family of enzymes catalyzes the production of nitric oxide from L-arginine 
(Förstermann & Sessa, 2012). These isoforms, (endothelial, neuronal, and inducible) are 
encoded on separate chromosomes by separate genes (V. W. T. Liu & Huang, 2008).  
They share homology in regions involved in cofactor binding and have similar enzymatic 
mechanisms that involve electron transfer for oxidation of the terminal guanidine 
nitrogen of L-arginine. All NOS proteins produce nitric oxide when flavins such as flavin 
adenine dinucleotide and flavin mononucleotide transfer electrons from NADPH to the 
heme in the amino terminal oxygenase base (Förstermann & Sessa, 2012). These 
electrons are then used to reduce and activate oxygen and oxidize L-arginine to L-
citrulline and NO. This flow of electrons requires intracellular calcium (Zhao, Vanhoutte, 
& Leung, 2015). An increase in calcium causes calmodulin affinity to NOS to increase 
and this increase facilitates the flow of electrons from NADPH to the oxygenase domain.  
  Our study was primarily concerned with eNOS or endothelial nitric oxide 




stimuli, the primary ones being fluid shear stress and pulsatile stretch. Often calmodulin 
binding alone cannot result in NO production, because the enzyme is dependent on 
protein phosphorylation and dephosphorylation (Förstermann & Sessa, 2012).  
2.7.1 Endothelium Derived Relaxing Ractor is nitric oxide 
  Before 1980, it was known that acetylcholine caused vasodilation of arteries and 
veins; however, the process by which this occurred was not fully understood until 
Furchgott and Zawadzki’s realization that acetylcholine does not cause relaxation in the 
absence of the endothelium. In their experiment, thoracic aortas were excised from 
rabbits and 2.5 mm rings were cut. Some were prepared with special care to keep the 
endothelium intact while the others underwent rubbing in order to remove the 
endothelium. The thoracic aortas that had endothelial cells responded normally to 
acetylcholine, while the other aortas had a lessened capacity to relax in the presence of 
acetylcholine. This led to the theory of an endothelium-derived relaxing factor (EDRF). 
To verify that this factor was coming from the endothelium and not the adventitial 
surface, the adventitia was also rubbed off, but this had no effect on the relaxation 
capacity of the aortic tissues (Zawadzki, 288AD).  
In 1987, Louis Ignarro hypothesized that the endothelium-derived relaxing factor 
discovered by Furchgott was actually nitric oxide. Ignaro mounted 3 portions of bovine 
main pulmonary artery and vein one on top of the other and perfused them with 
oxygenated Krebs bicarbonate solution. The strips were superfused with EDRF and NO 
at different times, and the magnitudes and decrement of relaxation down the cascade of 




Cyclic GMP levels, which were determined by monitoring the relaxation of the 
strips and tone during quick freezing, were also comparable after being perfused with 
calcium ionophore. The final experiment determining the chemical identification of 
EDRF as NO, involved perfusing one of the three strips to delay relaxant responses. The 
strips were perfused with either NO or perfusion media. An assay based on the 
diazotization of sulfamic acid by NO was used to quantitate the NO released. The EDRF 
was detected chemically as NO (Ignarro, Buga, Wood, & Byrns, 1987).  
2.7.2 EDRF is released by endothelial nitric oxide synthase 
In 1995, Paul Huang began to study the role of endothelial nitric oxide synthase in 
vascular function by disrupting the gene encoding eNOS. Endothelial nitric oxide 
synthase mutant mice were generated by homologous recombination. A Western blot 
showed that eNOS was present in the wild type samples but not in the eNOS mutant 
samples. The aortas were then dissected from the mice and mounted on tungsten wires in 
conventional myographs after which they were exposed to increasing concentrations of 
acetylcholine. The wild type mice responded with dose-dependent relaxation, while the 
mutant type showed no relaxation.  To determine blood pressure, mice were 
anaesthetized with urethane or halothane and pressure recordings were taken. For awake 
measurements a femoral artery catheter was used. The blood pressure for wild type mice 
was 81, 90, and 97 mm Hg for urethane, halothane, and awake, respectively while the 
blood pressure for mutant mice was 110, 109 and 117 for urethane, halothane, and awake, 
respectively These experiments proved that mice lacking endothelial nitric oxide synthase 
are hypertensive and lack EDRF activity, implicating endothelial nitric oxide synthase as 





2.7.3 Alternative techniques to measure nitric oxide 
 There are currently several techniques used to measure nitric oxide either directly 
or indirectly. Each of these techniques has advantages and limitations often linked to their 
sensitivity and specificity. It was the analysis of these methods that led to the search for a 
more ideal approach to measuring nitric oxide.  
Diaminonaphthalene assay 
The diaminonaphthalene assay is a type of fluorometric determination that utilizes 
the reaction of aromatic diamino compound 2,3-diaminoaphthalene with nitrous acid to 
produce a highly fluorescent product known as 2,3-napthotriazole to be used as an 
indicator of NO formation (Bryan & Grisham, 2008). The advantage of this assay is its 
specificity, sensitivity, and versatility.  
Diaminofluorescein-2 (DAF-2) may also be used to determine the presence of 
nitric oxide. Nitrosation of the diamino group results in a nitrosamine, which through an 
internal rearrangement forms the fluorescent triazole. DAFs contain a benzoic group 
attached to a fluorophore. Fluorescein is widely used as a fluorophore because of its 
convenient wavelengths, high extinction coefficient and high fluorescence quantum yield 
in water. A potential problem with DAF-2 and its related compounds is that ascorbic acid 
and dehydroascorbic acid can react with these probes and reduce their ability to detect 
NO (Bryan & Grisham, 2008).  
Colorimetric (Griess Reaction) Method 
Because nitric oxide is so hard to measure, some methods focus entirely on 




described by Johann Peter Griess in 1879, involves the reaction between nitrite and 
sulfanilic acid to form a diazonium cation which then couples to N-naphthyl-
ethylenediamine, forming a stable azo compound (See figure 2.4). (Griendling & Zweier, 
2016; Sun et al., 2003). This purple product has an absorbance linearly proportional to 
the nitrite concentration which can be measured by one of three methods: 
spectrophotometry, fluorescence, or HPLC (Griendling & Zweier, 2016; Sun et al., 
2003).  One advantage of using the Griess reaction is that these products are relatively 
stable, unlike nitric oxide. The main drawback of the Griess Reaction for our purposes is 
that it is typically used to quantitate nitric oxide in fluids, such as blood and urine, not in 
endothelial tissue. Furthermore, the insensitivity of this method makes endothelium- 
derived nitrite difficult to quantitate.  
 
Electrochemical Approaches 
 There are several electrochemical approaches to measuring nitric oxide; however, 
they all involve microelectrodes coated so that they are selectively permeable to nitric 
oxide (Griendling & Zweier, 2016). For example, in 1996 Tschudi and his team directly 
measured nitric oxide with a porphyrinic microsensor in order to study the effects of 
aging on NO release in isolated blood vessels. This porphryinic microsensor was used 
previously by Malinski to measure nitric oxide in rat brain (Malinski, Bailey, Zhang, & 
Chopp, 1993). This sensor was constructed by taking a pulled L-shaped glass capillary 
and threading 5 to 10 carbon fibers through it so that 5 mm of the fibers were protruding 
from the end. A copper wire was inserted into the opposite end of the capillary and then 




conductive polymeric film from a 0.25 mM solution of nickel (II) tetrakis porphyrin in 
0.1 M NaOH under N2. It was placed in 1% Nafion solution in alcohol for fifteen seconds 
and then allowed to dry. The porphryinic microsensor is advantageous because it is 
highly sensitive, small in size and has a fast response time (this is ideal because NO has a 
short half-life). Rats ranging from 5 months to 33 months old were sacrificed and their 
aorta and pulmonary arteries were harvested. The arteries were cut into 5 mm rings, then 
cut open longitudinally and pinned to the bottom of an organ chamber filled with HBSS 
buffer. The microsensor was then used to measure nitric oxide. The drawbacks of this 
sort of electrochemical detection are instability and low sensitivity of electrodes (Tschudi 
et al., 1996).  
Chemiluminescence 
 Chemiluminescence is a technique that can measure nitric oxide directly by its 
reaction with ozone (Bryan & Grisham, 2008). When nitric oxide reacts with ozone, it 
forms nitrogen dioxide in an excited state, which emits a photon that can be measured 
upon decay to ground state; however, only 8% of the nitrogen dioxide is formed in the 
excited state due to quenching. One solution to this problem is using modern 
photomultiplier tubes. Photo multipliers contain cathodes inside a vacuum tube that cause 
a photon to emit an electron due to the photoelectric effect. The photomultiplier tubes 
then multiply this electron creating a shower of new electrons. This allows 
chemiluminescence to measure NO in parts-per-billion.  
 Figure 2.5 is a basic diagram of a chemiluminescence apparatus which typically 
includes a carrier gas (nitrogen), sample chamber, cold trap, and NO analyzer. The carrier 




due to high availability and low cost. The carrier gas bubbles through the liquid sample 
removing the nitric oxide. The cold trap then prevents the sample and water vapor from 
being suctioned into the NO analyzer. The NO analyzer draws a gaseous stream at rates 
higher than 200 cc/min.  
 One major drawback of chemiluminescence is that it can only analyze nitric oxide 
in its gas phase. It is difficult to extract gas-phase NO from thin tissue samples (such as 
mouse aorta) without damaging the sample, especially with a gas flow rate higher than 
200 cc/min. The nitric oxide level also has to be high enough to raise the photomultiplier 
signal above the background level. However, chemiluminescence is excellent for large 
samples with high amounts of nitric oxide.  
 Another drawback to chemiluminescence is its lack of selectivity. 
Chemiluminescence measures any product that generates light upon reacting with ozone; 
unfortunately, nitric oxide is not the only compound that does this.  
 Electron Paramagnetic Resonance and Spin Trapping  
Unlike chemiluminescence, Electron Paramagnetic Resonance (EPR) is a specific and 
sensitive indirect way of detecting nitric oxide (Liebert, 2004).  Electron Paramagnetic 
Resonance or EPR is a technique that identifies and quantifies free radicals by responding 
to the transition of electron spins between energy levels; however, while nitric oxide is a 
paramagnetic material, it is so short lived that spin trapping must be used (Xu, Gu, & 
Qian, 2012). Spin traps react covalently with free radicals to form stable adducts in an 
addition reaction with a nitrone or nitrose compound (Xu et al., 2012). There are various 
spin traps for NO including hemoglobin, Fe complexes, and nitronyl nitroxides. 




2016). Iron-dithiocarbamate (Fe-DTC) spin traps are the most commonly used in ex vivo 
NO detection (Liebert, 2004). In these experiments, organs are harvested and placed in an 
EPR sample cell (tissue cell) before EPR signals are recorded (Liebert, 2004). Because 
EPR NO spin trapping uses spectroscopy as opposed to colorimetry, it has the unique 
capability of identifying the origin of the nitrogen and oxygen atoms that comprise nitric 
oxide (Liebert, 2004). This showed that the source of nitrogen in nitric oxide was L-
arginine. 
2.7.4 Using Diaminofluorescein to measure nitric oxide 
Diaminofluorescein was first developed as a fluorescent indicator for nitric oxide 
by Kojima and his team in 1998 (Kojima et al., 1998).  They wanted to track the nitric 
oxide production in a direct, real time fashion. Other methods had been developed, but 
they lacked selectivity, sensitivity, and experimental practicality. They found that he 
could utilize the reaction between nitric oxide and aromatic amines to produce triazenes.  
They decided to combine the fluorescent properties of fluorescein with the reactive 
properties of amine by using fluoresceinamine; however, the fluorescence was 
diminished due to the electron donating group attached to the phthalic ring of fluorescein. 
Because of this limitation, he designed and synthesized 4,5-diaminofluorescein or DAF-
2. To test this new indicator, the DAF-2 was applied to cultured rat aortic smooth muscle 
cells and then imaged via a fluorescence microscope. The excitation and emission spectra 
of DAF-2 were measured before and after the reaction with nitric oxide. The excitation 
was measured at 495 nm while the emission was measured at 515 nm.  
 In 2003, Räthel and his team sought to measure miniscule levels of nitric oxide 




and sensitivity that pervades many other methods. Human endothelial cell lines were 
used in the assays, and the fluorescent supernatants were measured and analyzed. The 
DAF-2 was administered at different concentrations of 0.01 µM, 0.1 µM, 1 µM and 5 µM 
before and after nitric oxide was released from endothelial cells. DAF-2’s ability to detect 
nitric oxide increases as the concentration of DAF-2 decreases. To determine if 
concentrations < 1 µM of DAF -2 detect all nitric oxide, They made two standard curves 
with one comparing fluorescence intensity to increasing concentrations of DAF-2 and the 
other to increasing concentrations of NO liberated from donor NOC-9. A major limitation 
of this method is that it doesn’t enable measurement of nitric oxide directly on the tissue.  
Another is that the sensitivity of the spectrofluorometer has to be fairly high (Räthel, 
Leikert, Vollmar, & Dirsch, 2003). 
2.7.5 Effect of age on kinetics of nitric oxide release in rat aorta 
Several studies support the claim that nitric oxide production decreases with age. 
The first is by Tschudi and his team, who used a porphyrinic NO microsensor to detect 
nitric oxide release in young and old isolated rat aortas. After 10 umol/liter of calcium 
ionophore was administered, the microsensor measured a higher release of nitric oxide in 
young aorta than in old aorta (Tschudi et al., 1996).  
Hongo and his team (1988) studied the effects of both aging and hypertension on 
endothelium-dependent vascular relaxation in rat carotid artery. Four different types of 
rats were used, young and old Wistar Kyoto (WKY) rats as well as young and old 
spontaneously hypertensive rats (SHR). The common carotid artery was removed from 
the rats and cut into 3 mm long rings. The resting tension was set at 2 grams, and 5-




relaxation induced was calculated as a percentage of the contraction induced. The 
percentages were as follows: 70.1for the young WKY, 45.6 in the old WKY, 35.1 in 
young SHR and 21.4 in old SHR (Hongo et al., 1988).  
In 1998, Chou and his team studied the decrease in expression of endothelial 
nitric oxide synthase with aging and hypertension in rats. This was done by first 
separating spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) into 4-
week, 14-week and 63-week time points. After removal of the aortas, NOS activity and 
expression were measured by using L-citrulline formation and Western blot analysis, 
respectively. While nitric oxide synthase activity went down somewhat with age in the 
WKY rats (from 0.79 for the 4-week rats to 0.71 for the 63-week rats), eNOS expression 
in the SHR went down much more dramatically (from 0.78 for the 4-week rats to 0.34 for 
the 63-week rats). The Western blot analysis showed very similar results, with WKY and 
SHR showing similar eNOS protein expression in the beginning, but with the SHR 
decreasing significantly with age and WKY staying relatively constant (Chou, Yen, Li, & 
Ding, 1998).  
Another study on nitric oxide production was performed by Kevin Soucy (2006). 
Soucy demonstrated the diminution of nitric oxide production with age using two 
different techniques. He first did this by comparing the endothelium-dependent 
vasorelaxation response in young and old aortas. To measure the vasodilation response, 
aortic rings from both old and young rats were placed in 25 ml organ chambers and 
suspended from a strain gauge. The vasorelaxation was calculated by percent decrease in 
tension from the phenylephrine-induced preconstriction. The older aortas expressed less 




decreasing, it did not rule out other factors that can cause an endothelium-dependent 
vasorelaxation response (Soucy et al., 2006). 
 Using fluorescence and a flow chamber system, Soucy was able to measure NO 
production rates. The chamber system simulates the shear stress in the human body that 
induces nitric oxide production. A monochromator-based spectrofluorometer and an 
inverted fluorescence microscope measured lower nitric oxide production in the older 
rats.  
In 2010, Zanetti and her team, like Chou, also showed that endothelial nitric oxide 
synthase protein decreases with age. Protein levels of eNOS as well as several other 
proteins were measured using Western blot analysis. Results showed that eNOS 







Figure 2.1: Structure of the arterial wall: Three layers comprise the 
arterial wall: the tunica externa, the tunica media, and the tunica interna. 
The tunica interna or the intima includes the lumen of the blood vessel 
which is lined with endothelial cells. The tunica media is composed of 
smooth muscle cells, while the tunica externa contains fibrous connective 
tissue. Adopted from ‘Hyperelastic modelling of arterial layers with 
distributed collagen fibre orientations’ by T. C. Gasser, 2006, Journal of 






Figure 2.2: Structural adaptations due to hypertension: In response to 
increased blood pressure, the artery adapts by changing the media to 
lumen ratio by changing the thickness of the vessel wall as seen in (A)and 
(B). In response to changes in flow, the vessel adapts by changing the 
dimensions of the lumen as seen in (C) and (D). Injury, such as an 
atherosclerotic lesion, can result in either outward vessel remodeling or 
occlusion as shown in (E) and (F). Adapted from ‘Pathophysiology of 
Vascular Remodeling in Hyptertension’ by N. F. Renna, 2013, 








Figure 2.3 Vascular remodeling due to hypertension: In response to 
increased blood pressure, the artery adapts by changing the media to 
lumen ratio by changing the thickness of the vessel wall. This is called 
elastic distension. Endothelin 1, a vasoconstrictor increases as nitric oxide 
decreases and the vessel vasoconstricts. This results in the remodeling of 
the arterial wall. Adapted from ‘A Mixture Model of Arterial Growth and 
Remodeling in Hypertension: Altered Muscle Tone and Tissue Turnover’ 
by R.L. Gleason & J.D. Humphrey, published by Journal of Vascular 







Figure 2.4: Griess Reaction Assay: Nitrite is treated with a diazotizing 
reagent such as sulfanilamide (SA) to form a diazonium salt. This salt then 
reacts with N-naphthyl-ethylenediamine (NED) forming a stable azo 
compound. The product releases an intense purple color with an 
absorbance of 540 nm. Adapted from ‘Measurement of Nitric Oxide in 




















Figure 2.5: Setup of NO chemiluminescence instrument: NO related components are 
reduced to NO gas and carried into NO analyzer. Cold trap, NaOH-filled trap, and filter 
protect analyzer against humidity and acid vapors. In reaction chamber, NO gas is 
combined with O3 from O2 tank. Signal is detected by photomultiplier tube and amplified. 
Adapted from ‘Measuring Nitrite and Nitrate, Metabolites in the Nitric Oxide Pathway, 
in Biological Materials using the Chemiluminescence Method.’ By Barbara Piknova, 





MATERIALS AND METHODS 
3.1 INTRODUCTION 
In this experimental design, there were two timepoints: 6 weeks and 6 months. However, 
mice that are 6 months old have not aged enough to adequately mirror the vascular 
dysfunction that normally occurs in elderly human patients. To rectify this shortcoming, 
it was decided to place some of the mice on a Western diet for 6 months to cause them to 
develop atherosclerosis and hence more closely mimic the endothelial dysfunction seen 
in aging humans.  
In this experiment groups of mice (n=5) were placed on either a high fat Western diet or a 
chow diet for 6 months. Young mice at 6 weeks of age on chow diet served as the 
baseline. The mice were sacrificed and the organs harvested. Samples of the aorta were 
taken from the region of the fourth intercostal arteries and from the abdominal infrarenal 
segment. These samples were placed in 4% paraformaldehyde (PFA), processed 
overnight and embedded in paraffin. The blocks were then sectioned at a thickness of 6 
µm. 
3.2 Immunoperoxidase Staining Procedure 
 To deparaffinize the sections, the slides were placed in Histoclear twice for five 




times for 30 seconds, in 95% ethanol twice for 30 seconds and once in 70% ethanol. 
Finally, they were set in distilled water twice for thirty seconds.  
 After deparaffinization, the slides were washed for five minutes in 1X filtered PBS.  
Then the endogenous peroxidase was blocked via a 5-minute incubation in 3% H2O2 at 
room temperature. The slides were then washed twice for five minutes in 1X filtered PBS. 
 Antigen retrieval was performed using the citrate buffer technique. Citrate buffer 
(pH 6.0) was preheated to 50-60 degrees C in a large beaker. The slides were placed in the 
beaker and the buffer was heated to boiling for 10 minutes. Afterwards, the slides were 
removed from the heat and allowed to cool for at least 10 minutes.  
 The slides were blocked with 10% goat serum in 1X PBS for 1 hour in a humid 
chamber at room temperature. Rabbit anti-eNOS primary antibody was prepared in 10% 
goat serum at 1:75 dilution. The slides were incubated for 2 hours with primary antibody. 
The slides were washed twice for five minutes in 1X PBS and then incubated with 
secondary antibody (biotin-labeled- goat anti-rabbit IgG at 1:100 dilution in 10% goat 
serum) for 2 hours in a humid chamber at room temperature.  The HRP-streptavidin 
dilution was made with at a 1:250 ratio in 50 mM tris HCL (pH 7.2).  After the secondary 
antibody incubation, the slides were washed twice for five minutes in 1X filtered PBS.  
 The slides were incubated with HRP-streptavidin solution for 1 hour in a humid 
chamber at room temperature. The excess solution was then discarded, and the slides were 
washed two times for 5 minutes in 1X filtered PBS.  Meanwhile, a Vector DAB 
(diaminobenzidine) substrate was made from a kit according to the manufacturer’s 
instructions and protected from light. 100 µl of Vector DAB substrate was layered on the 




using the positive control and this development time was applied to the rest of the slides in 
batches of four. There were five different batches total. After development, each slide was 
transferred to reagent-grade water.  
 Next the slides were stained for 1 minute and 30 seconds in hematoxylin, then 
washed twice for 30 seconds in distilled water. They were dipped one time in 70% acid 
alcohol and ten times in Scott’s solution. After this, they were washed for two minutes in 
distilled water.  The sections were then dehydrated. To dehydrate the slides, they were first 
dipped ten times in 70% ethanol, ten times in 95% ethanol, and ten times in 100% ethanol. 
They were then placed in Histoclear once for five minutes and once for three minutes. 
Coverslips were mounted using Permount and allowed to dry before storing. 
3.3 Immunofluorescence Staining Procedure 
 Immunoperoxidase and immunofluorescence staining procedures were compared 
to achieve the best possible images for quantitation. For immunofluorescence, 
deparaffinization was performed as described above for the immunoperoxidase staining 
protocol. 
 After deparaffinizing, antigen retrieval was performed on the slides. The citrate 
buffer (pH 6.0) was heated via hot plate to 60 C. The slides in the beaker were heated to 
boiling for ten minutes. Afterwards, the slides were removed from the heat and allowed 
to cool for at least ten minutes.  
 Next, the slides were blocked with 10% donkey serum in PBS for 1 hour in a 
humid chamber at room temperature. The primary antibody (rabbit anti-eNOS antibody) 




primary antibody for 2 hours in a humid chamber at room temperature. The slides were 
then washed twice for five minutes in PBS.  
The secondary antibody was prepared in the dark at 1:100 Rhodamine Red X 
(RRX) – donkey anti-rabbit IgG in 1X PBS. Slides were incubated in the dark with 
secondary antibody for 2 hours. (All steps after this were completed in the dark.) The 
slides were then rinsed twice for five minutes in 1 X PBS at room temperature. Hoechst 
stock solution was centrifuged for 10 minutes at 1000 rpm before use. The slides were 
counterstained for 5 min in 1: 10000 Hoechst 33258 in 1 X PBS at RT and rinsed twice 
for 5 minutes in 1X PBS at room temperature. The slides were then rinsed briefly in 
distilled water and coverslips were applied with 1-2 drops of Dako fluorescent mounting 
medium. 
3.4 Fluorescence Quantification 
Fluorescent images were acquired using an Axiovision Imager.A1 microscope 
(Zeiss) with an exposure time of 250 ms, a time weight of 28% and a digital gain of 8. 
The brightness was -0.50, the contrast was 1.00 and the gamma setting was 1.50. Three 
filters were used: DAPI, FITC and Rhodamine. Images taken with each filter were 
merged in ImageJ software. Since the entire aortic cross section did not fit within the 
field of view at 200X magnification, the samples were imaged by tiling, and the Kolor 
Autopano software was used to stitch together images to visualize the complete cross 
section. The red channel, containing the eNOS-specific staining, was extracted. The 
aortic endothelium was manually traced using the polygon option in the ‘Measurements’ 
menu of ImageJ, to determine its area. To quantify area of positive staining for 




over the endothelium again. The intensity range was set to 76-255 for segmentation of 
eNOS staining. The total segmented area was selected and summed up using the ‘count 
objects’ function. The eNOS positive area was divided by the total endothelial area to 
give percent eNOS expression.  
3.5 DAF-2 Measurement with IVIS 
This procedure is based on the published method of Ozaki. Pinning dishes were 
prepared by coating the bottom of 60 x 15 mm tissue culture dishes with a ~3 millimeter 
thick layer of black wax (Ozaki et al., 2002). Mice were sacrificed by carbon dioxide 
asphyxiation and perfused for 5 min with heparinized saline to flush blood from the 
circulation. The thoracic aorta (from the aortic arch to the diaphragm) was excised, 
opened longitudinally, and mounted en face in a prepared pinning dish with stainless steel 
insect pins (see figure 3.1).  
The dissected aorta was placed temporarily in 5 ml PBS (pH 7.4) and refrigerated 
until all specimens had been prepared (this was done within 8 hours).  Once all the 
arteries had been extracted, the PBS was replaced with 0.1 mol/l phosphate buffer (pH 
7.4) containing 1.5 mmol/l calcium chloride. Each sample was placed in the IVIS with B 
selected as the field of view. The samples were imaged with excitation at 465 nm and 
emission at 520 nm with a high lamp level. After bringing the image into focus, three 
pictures were taken: one with F2 medium binning, another with F2 small binning, and a 
third with F1 small binning. The sample was removed from the IVIS and 50µl of DAF-2 
DA was added to the dish to yield a final concentration of 10µmol/l. After a 5-minute 
incubation, three new images were taken with the same settings as the previous three. 5 




an additional 5 minutes. A final set of three images was taken with the same settings as 
the previous ones.  
 The result was three sets of images representing background fluorescence (no 
DAF), unstimulated NO release, and ACh- stimulated NO release. The background 
fluorescence was used as a negative control and was subtracted from the other two sets of 
images during quantification. The second set of images only had the DAF-2 treatment 
while acetylcholine, which stimulates nitric oxide release, was applied to the specimen in 
the third set.  
 3.6 IVIS 
To image the thoracic aortas with DAF-2, we used the IVIS Spectrum (In Vivo Imaging 
System manufactured by PerkinElmer).  
Binning 
Pixel binning is a procedure that combines a cluster of pixels into a single pixel in 
order to reduce noise, and to improve the signal-to-noise ratio and frame rate. For 
example in 3x3 binning, 9 pixels would become 1. While this does result in a loss of 
information, binning data also reduces read noise on the processed image.  The IVIS has 
three different settings for binning – Low, Medium and High, with low binning providing 
the highest resolution (but longer processing time) and high binning providing the lowest 
resolution (but shortest processing time).  
Field of View 
The IVIS spectrum has a static camera and therefore the field of view is changed by a 
stage that moves up and down. The IVIS spectrum has 5 preset heights for the stage 












Figure 3.1: Depiction of the aortic tree denoting the dissection 
procedure. Adopted from ‘Aorta Atherosclerosis Lesion Analysis 
in Hyperlipidemic Mice’ by Changjun Yin, 2016, bio protoc 
journal, copyright 2016, published by PubMed Central 
Figure 3.2 Schematic of an In Vivo Imaging System (IVIS): adapted 







4.1 Immunoperoxidase Staining 
 Figure 4.1 shows representative immunoperoxidase staining of aortic tissue 
segments from chow diet-fed and Western diet-fed mice varying in age from 6 weeks to 6 
months. Panels A – C show the immunoperoxidase staining of aortic tissue segments 
taken from the abdominal aorta while Panels D- F show the immunoperoxidase staining 
of aortic tissue segments taken from the level of the fourth intercostal arteries. Panel G is 
the negative control. The development time was 1 minute and 30 seconds.  
 Figure 4.2 provides a bar graph illustrating the average percent eNOS expression 
in the intima for each mouse experimental group. The average eNOS % expression for 
intercostal 6 week chow, 6 month chow, and 6 month Western Diet in the intercostal 
segment was 15.3 ± 5.7, 13.26 ± 9.99, 24.45  ± 22.65, respectively. The average eNOS 
% expression for abdominal 6 week chow, 6 month chow, and 6 month Western diet was 
abdominal segment 18.93 ± 9.05, 9.08 ± 4.41, 12.00 ± 19.28. There was no significant 
difference between these measurements when conducting an ANOVA test.  
4.2 Immunofluorescence Staining 
 Immunofluorescent staining was performed on chow diet-fed and Western diet-
fed mice varying in age from 6 weeks to 6 months. These segments were taken from the 




arteries. The fluorescent staining did not work as well as the immunoperoxidase staining 
due to nonspecific staining in the media, so the data was not used.  
4.3 DAF -2 Staining 
Figure 4.4 provides a bar graph illustrating the average percent NO release for 
each experimental group, measured as integrated fluorescence intensity over the tissue 
area. To determine the NO release in the samples, the negative control value was used as 
a baseline and subtracted from the integrated intensity values in the DAF-2 and 
acetylcholine-treated samples. Integrated fluorescence intensity values were separated by 
tissue treatment (DAF-2 alone vs DAF-2 plus acetylcholine) as well as by mouse age and 
diet. As shown in figure 4.5, acetylcholine treatment induced an increase in DAF-2 
fluorescence for all experimental groups, as expected.  
Figure 4.5 provides a bar graph illustrating the average percent NO release for the 








Figure 4.1: Immunoperoxidase Staining: Immunoperoxidase staining of arterial 
sections of ApoE knockout mice taken from the abdominal aorta at (A) 6 weeks and (B-C) 
6 months. (A-B) Chow diet. (C) Western diet. Immunoperoxidase staining of aortic 
sections of ApoE knockout mice taken from the level of the fourth intercostal arteries at 















Figure 4.2: Mean Immunoperoxidase Data: Mean endothelial nitric oxide synthase 
expression in ApoE knockout mice obtained via immunoperoxidase staining at 6 weeks or 
after 6 months on diet for the three treatment groups. No significant differences between 


































Figure 4.3: DAF-2 Staining: DAF-2 staining of longitudinally cut thoracic arteries of 
ApoE knockout mice. (A,D&G) are controls, (B,E,&H) contained DAF-2 only, and 
(C,F,&I) contained both DAF-2 and acetylcholine. A-C were 6 weeks and D – I were 6 






















































Figure 4.4:  DAF-2 Nitric Oxide Expression Data: Nitric Oxide 
expression in ApoE knockout mice obtained  via DAF-2  at 6 
weeks or after 6 months. Measurements were taken after the 
administration of Acetylcholine. A single factor ANOVA test was 
conducted and no significant difference was found.  
Figure 4.5: DAF-2 Nitric Oxide Expression Data by Age: Mean 
nitric oxide expression in ApoE knockout mice obtained via DAF- at 
6 weeks or after 6 months on diet for the three treatment groups. A 
significant difference was found using a two-sample t-test assuming 







5.1 Introduction  
In her dissertation, “Factors Influencing the Collagen Fiber Angle Distribution in 
The Mouse Aorta,” Dr. Shana Watson used second-harmonic generation microscopy to 
demonstrate that collagen fiber angle changes with age. What she did not determine was 
the cause of the collagen remodeling. The first hypothesis tested was that changes in 
hemodynamics were driving collagen fiber reorganization; however, no differences with 
age were found in physiological variables such as blood pressure and blood flow velocity. 
Therefore, it was hypothesized that a decrease in nitric oxide was responsible for the 
collagen fiber angle change. The purpose of this study was to determine if the changes in 
collagen fiber angle with age were related to decreased nitric oxide production in the 
arterial wall. This was done by measuring nitric oxide both directly and indirectly in mice 
with ages, diet, and genotype identical to the mice used in the previous experiments.  
5.2: Aim 1 
Measuring protein expression via Immunoperoxidase staining demonstrated that 
for ApoE knockout mice, between the age of 6 weeks and 6 months, there is no 
significant difference in endothelial nitric oxide synthase expression with age or diet. The 
methods used produced a high level of variability. This is most likely due to the fact that 




of the entire aorta. These results were very unexpected because most of the studies 
described in the literature have shown that endothelial nitric oxide synthase decreases 
with age; however, it does nothing to disprove our hypothesis that a decrease in nitric 
oxide is responsible for changes in collagen fiber angle. This experiment (for Specific 
Aim I) detected eNOS protein expression, not activity. While endothelial nitric oxide 
synthase protein expression remained the same, its activity might have gone down. The 
regulation of eNOS activity is a complex process that involves more than just temporary 
rises in intracellular calcium concentration. It also involves fatty-acid modifications, 
caveolin, availability of arginine, cofactors such as BH4, and phosphorylation at Ser 1179 
and Thr 497 (Huang, 2003). There are two types of fatty acid modifications that alter 
eNOS activity: myristoylation and palmitoylation. Both fatty acid modifications are 
crucial for eNOS to generate nitric oxide. Myristoylation, a process necessary for eNOS 
to become membrane-associated, occurs when an aminopeptidase exposes the glycine at 
the N terminus of eNOS. When the glycine has been mutated, myristoylation does not 
occur resulting in a soluble protein that produces significantly less nitric oxide 
(Udenwobele et al., 2017). Palmitoylation is also required for the proper localization of 
eNOS to the membrane, specifically to domains called caveolae (Huang, 2003).  
Furthermore, other factors, such as the amount of superoxide formation in vessels, can 
also influence the bioavailability of nitric oxide even if nitric oxide synthase activity is 
high (Huang, 2003). If nitric oxide reacts with a superoxide anion to form peroxynitrite 
anion it is impossible for the nitric oxide to regulate vascular tone. 
 Smith and colleagues showed that the phosphorylation of eNOS significantly 




acetylcholine-induced relaxation of both young and old mouse aorta and determined that 
relaxation was significantly reduced for the older mice (Smith et al., 2006). Western blot 
analysis was then used to show that there was no reduction of eNOS protein levels with 
age (Smith et al., 2006). The endothelia of rat aortas were subjected to Western blot using 
antibodies to specific phosphorylation sites of the eNOS protein to determine whether the 
protein had undergone phosphorylation. Results revealed that eNOS showed reduced 
phosphorylation (a decline of 71%) at the S1176 site with age. This study showed that 
while eNOS protein expression can stay the same, nitric oxide bioavailability can 
decrease with loss of phosphorylation.  
 There have also been studies that have noted an increase in eNOS expression with 
age such as Donato’s study (Donato et al., 2009). The study first notes that healthy 
endothelium-dependent dilation is impaired in adult humans but then admits that the 
reason for this is unclear. The authors go on to recognize that nitric oxide is the “most 
important vasodilatory molecule synthesized by the endothelium”. Hence, the purpose of 
this study was to determine if endothelial nitric oxide synthase is responsible for changes 
in NO production. However, unlike our study which used mice, the study by Donato, et 
al. used human subjects. Endothelial cells were collected by advancing J-wires into the 
brachial artery and then withdrawing them. The cells collected were transferred to slides 
and stained. The authors observed that both eNOS and its phosphorylated isoform 
increased with age.  
These results contradict those described in most of the literature on nitric oxide 
synthase expression with age. In the study by Smith and colleagues, the differences in 




category, whereas other studies used at least 100 rats (Chou et al., 1998). Donato’s study 
also included a relatively small of number of subjects. They used 56 healthy,18-78 year 
old males (less than 30 for each category) (Donato et al., 2009). If these men are healthy 
at 78 years of age, they probably ate right and exercised, both of which raise nitric oxide 
levels. Donato’s study is different from the current work since he used humans instead of 
mice; however, this is significant because the whole point of testing mice is to infer what 
is happening in the human vasculature. Most of the studies that found decreased 
endothelial nitric oxide synthase with age used rats, not mice. This could mean that mice, 
for this one experiment, represent what is happening in the human vasculature more 
accurately than rats.  
Because there is evidence that nitric oxide bioavailability does not necessarily 
correspond to nitric oxide synthase expression, the only way to determine if nitric oxide 
is responsible for changes in collagen fiber angle is to measure it directly.  
5.3 Aim 2  
 Directly measuring nitric oxide via DAF-2 demonstrated that, for ApoE knockout 
mice between the ages of 6 weeks and 6 months, there is no statistical difference in basal 
or acetylcholine-stimulated nitric oxide levels with age or diet. These results corroborate 
our nitric oxide synthase protein expression findings. However, when divided solely by 
age there was a significant increase. This is probably due to the fact that with age the 
arteries enlarge, and nitric oxide increases with blood flow. While these results seem to 
contradict the literature, most of the literature that showed nitric oxide expression 




young to show vascular dysfunction. They started with mice that were a lot older or they 
used rats that were a lot older. So, while it may remain true that at a certain age, nitric 
oxide begins to decrease, these findings do not support the hypothesis that a decrease in 
nitric oxide production is responsible for the collagen remodeling seen in previous 
experiments. 
 Many factors besides nitric oxide play a role in establishing the basal arterial tone. 
An alternative cause of collagen remodeling could be changes in the production of 
bradykinins, which cause cycloxygenase (found in the endothelium) to release 
prostacyclin – an effective vasodilator (Kirkby et al., 2012). Like nitric oxide, 
prostacyclin also inhibits platelet activation, helping to prevent atherosclerosis and 
endothelial dysfunction. Nitric oxide and prostacyclin are considered the most important 
cardioprotective paracrine factors. Prostacyclin synthesis begins when phospholipase A2 
releases arachidonic acid from membrane bound lipids (Mitchell, Ali, Bailey, Moreno, & 
Harrington, 2008). The arachidonic acid is metabolized by cyclooxygenase form 
prostaglandin H2, which is the substrate for downstream enzymes that eventually form 
prostacyclin. After being released by the endothelial cells, prostacyclin binds to cell 
surface receptors and activates the enzyme adenylate cyclase, which converts ATP to 
cAMP, which causing relaxation of the blood vessels. Like nitric oxide, prostacyclin 
release is dependent on intracellular calcium levels (Mitchell et al., 2008). Also, like 
nitric oxide, there have been studies showing that prostacyclin decreases with age. For 
example, in 1991, Tokunaga tested endothelial cells of human aortas for prostacyclin. 
Aortic tissues were obtained within 2 hours after death and were embedded in paraffin. 




radioimmunoassay kit. While Tokunaga found prostacyclin in all the subjects, the 
intensity of the prostacyclin expression was lower in the older subjects (Tokunaga, 
Yamada, Fan, & Watanabe, 1991).  
 Other possible factors that may alter basal arterial tone include vasoconstrictors 
such as thromboxane. Thromboxane has effects opposite to those of prostacyclin. While 
prostacyclin inhibits platelet activation, causes vessels to dilate, and reduces vascular 
smooth muscle cell remodeling, thromboxane increases platelet activation, causes vessels 
to constrict, and induces smooth muscle cell proliferation. Usually thromboxane and 
prostacyclin maintain a certain balance when the body is in homeostasis. However, 
sometimes they are out of balance, resulting in endothelial dysfunction. This can result 
from either a shortage of prostacyclin or an excess of thromboxane.  
5.4: Limitations of the study 
There were several limitations of this study. Most of the studies that found a 
decrease in nitric oxide with age used rats rather than mice and compared nitric oxide 
levels at ages much greater than 6 months. For example, Chou used 141 rats up to 63 
weeks old. Likewise, Tschudi used rats ranging from 6 months old to 33 months old. In 
Hongo’s experiment, rats were also used, at ages ranging from 14 weeks to 11 months. 
While Soucy used both rats and mice, his mice were almost a year old (twice the age of 
our own).  
 Another limitation is exclusive to the immunoperoxidase quantitation. Each 
arterial tissue section is only 6 µm in thickness; thus, even within a given region, the 




arterial cross-section gives a poor representation of nitric oxide synthase expression in the 
entire artery.  This is where the direct measurement of nitric oxide using DAF-2 becomes 
advantageous. Unlike immunofluorescence, our method using DAF-2 measured nitric 
oxide expression of the entire thoracic aorta. However, the DAF-2 method we used had 
its own limitation. Since nitric oxide release depends on the enzymatic activity of nitric 
oxide synthase, measuring nitric oxide using DAF-2 must be done rapidly after the tissue 
is harvested, since activity will diminish over time.  
5.5: Further Research 
 To overcome some of these limitations, further research is needed. First, this 
experiment should be redone with a larger population of mice It should also be done over 
a greater age range, similar to those investigated in published studies. The ages would 
include 6 weeks (young), 6 months (middle aged), and 1 year (old). The 6 months and 1 
year would also be separated according to diet (Western vs. chow). I predict that nitric 
oxide expression will start to resemble a bell curve rather than a linear progression. To 
eliminate the tissue sampling issues with immunofluorescence imaging, multiple sections 
can be taken from the tissue and averaged.  Another option is to use en face fluorescent 
staining which involves staining the entire thoracic artery.  
 However, since both the DAF-2 assay and immunoperoxidase staining show 
consistent results, it is reasonable to conclude that the results are accurate and not a 
sampling issue. So, if changes in nitric oxide production are not the cause of collagen 
remodeling, it might be that basal arterial tone is altered by imbalances in another 




determine whether basal arterial tone changes with age is to do myography to measure 








Our data indicates that there was no significant difference in endothelial Nitric Oxide 
Synthase (eNOS) expression between the groups for the immunoperoxidase staining. 
There was also no significant difference in Nitric Oxide release between the groups for 
the DAF-2 staining. The lack of a significant decrease with age disproves our hypothesis 
that a decline in nitric oxide is responsible for the re-orientation of collagen fibers in the 
arterial wall.  
An alternative cause of collagen remodeling could be changes in the production of 
bradykinins and thromboxane. Usually thromboxane and prostacyclin maintain a certain 
balance when the body is in homeostasis. However, sometimes they are out of balance, 
resulting in endothelial dysfunction. This can result from either a shortage of prostacyclin 
or an excess of thromboxane. The best way to determine whether basal arterial tone 
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